Metachronous lesions after gastric endoscopic submucosal dissection: first assessment of the FAMISH prediction score
Endoscopy · 01.10.2023 · 55 (10) · 909-917
DOI: 10.1055/a-2089-6849 ↗Kurz gefasst
Kommentar in der Zeitschrift Endoscopy, erschienen am 01.10.2023. Verfasst von Andreia Rei und 6 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology Department, Centro Hospitalar Universitário de Santo António, Porto, Portugal. Hauptthemen laut MEDLINE: Endoscopic Mucosal Resection, Helicobacter Infections, Helicobacter pylori, Stomach Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 35 Literaturangaben.
Abstract (Originalsprache)
Background
Surveillance after gastric endoscopic submucosal dissection (ESD) is recommended for all patients owing to the persistent risk of metachronous gastric lesions (MGLs). We developed and validated a prediction score to estimate MGL risk after ESD for early neoplastic gastric lesions, to define an individualized and cost-saving approach.
Methods
Clinical predictors and a risk score were derived from meta-analysis data. A retrospective, single-center, cohort study including patients with ≥ 3 years of standardized surveillance after ESD was conducted for score validation. Predictive accuracy of the score by the area under the receiver operating characteristic curve (AUC) was assessed and cumulative probabilities of MGL were estimated.
Results
The risk score (0–9 points) included six clinical predictors (scored 0–3): positive family history of gastric cancer, older age, male sex, corpus intestinal metaplasia, synchronous gastric lesions, and persistent Helicobacter pylori infection (FAMISH). The study population included 263 patients. The MGL rate was 16 %. The score diagnostic accuracy for predicting MGL at 3 years’ follow-up, measured by the AUC, was 0.704 (95 %CI 0.603–0.806). At 3 years and a cutoff < 2, the score achieved maximal sensitivity and negative predictive value; 15 % of patients could be assigned to a low-risk group, in which the progression to MGL was significantly lower than for the high-risk group (P = 0.04).
Conclusion
The FAMISH score might be a useful tool to accurately identify patients with low-to-intermediate risk for MGL at 3 years of follow-up who could have surveillance intervals extended to reduce the burden of care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Gastroenterology Department, Centro Hospitalar Universitário de Santo António, Porto, Portugal.
- Gastroenterology Department, RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto) and Porto Comprehensive Cancer Centre (Porto.CCC), Porto, Portugal.
- MEDCIDS, Faculty of Medicine, University of Porto, Porto, Portugal.
- Pathology Department, Portuguese Oncology Institute of Porto, Porto, Portugal.
ORCID-Profile: Andreia Rei, Raquel Ortigão, Mariana Pais, Pedro Pimentel-Nunes, Diogo Libânio
Zitieren
APA
Rei, A., Ortigão, R., Pais, M., Afonso, L. P., Pimentel-Nunes, P., Dinis-Ribeiro, M., & Libânio, D. (2023). Metachronous lesions after gastric endoscopic submucosal dissection: first assessment of the FAMISH prediction score. Endoscopy, 55(10), 909-917. https://doi.org/10.1055/a-2089-6849
Vancouver
Rei A, Ortigão R, Pais M, Afonso LP, Pimentel-Nunes P, Dinis-Ribeiro M, et al. Metachronous lesions after gastric endoscopic submucosal dissection: first assessment of the FAMISH prediction score. Endoscopy. 2023;55(10):909-917. doi:10.1055/a-2089-6849
BibTeX
@article{Rei2023,
author = {Rei, Andreia and Ortigão, Raquel and Pais, Mariana and Afonso, Luís P and Pimentel-Nunes, Pedro and Dinis-Ribeiro, Mário and Libânio, Diogo},
title = {Metachronous lesions after gastric endoscopic submucosal dissection: first assessment of the FAMISH prediction score},
journal = {Endoscopy},
year = {2023},
volume = {55},
number = {10},
pages = {909--917},
doi = {10.1055/a-2089-6849}
}
EUVIMED